CureVac N.V. (CVAC)
3.93
-0.01 (-0.25%)
At close: Jan 14, 2025, 3:59 PM
3.95
0.51%
Pre-market Jan 15, 2025, 04:03 AM EST
undefined% (undefined)
| Bid | 3.95 |
| Market Cap | 881.52M |
| Revenue (ttm) | - |
| Net Income (ttm) | - |
| EPS (ttm) | 0.48 |
| PE Ratio (ttm) | 8.19 |
| Forward PE | n/a |
| Analyst | Hold |
| Ask | 4 |
| Volume | 941,328 |
| Avg. Volume (20D) | 720,404 |
| Open | 3.97 |
| Previous Close | 3.94 |
| Day's Range | 3.92 - 4.20 |
| 52-Week Range | 2.21 - 5.28 |
| Beta | undefined |
About CVAC
CureVac N.V., a clinical-stage biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). It is developing prophylactic vaccines, such as mRNA-based vaccine candidates CV2CoV, which is in Phase 1 clinical trial against SARS-CoV-2; CV7202, a prophylactic mRNA-based vaccine, which has completed Phase 1 clinical trial for rabies virus glycoprotein; and CVSQIV, which is in Phase 1 cli...
Industry Biotechnology
Sector Healthcare
IPO Date Aug 14, 2020
Employees 999
Stock Exchange NASDAQ
Ticker Symbol CVAC
Website https://www.curevac.com
Analyst Forecast
According to 3 analyst ratings, the average rating for CVAC stock is "Hold." The 12-month stock price forecast is $10, which is an increase of 154.45% from the latest price.
Buy 33.33%
Hold 66.67%
Sell 0.00%
Next Earnings Release
CureVac N.V. is scheduled to release its earnings on Apr 23, 2025,
before market opens.
Analysts project revenue of $6.50M, reflecting a -73.51% YoY shrinking and earnings per share of -0.12, making a -70.73% decrease YoY.
Analysts project revenue of $6.50M, reflecting a -73.51% YoY shrinking and earnings per share of -0.12, making a -70.73% decrease YoY.
1 week ago ·
Source
+5.41%
Shares of vaccine makers are trading higher after ...
Unlock content with
Pro Subscription
1 week ago ·
Source
+5.41%
Shares of vaccine makers are trading higher after the first bird flu death was reporting in the US. Additionally, a recent DCD report noted an increase in acute respiratory illness activity.
